Okomera
Founded 2020 · 24 employees on LinkedIn · 2 known investors
Okomera builds a platform combining miniaturized tumor-on-chip technology and AI imaging to analyze patient-derived biopsies and predict personalized drug response for cancer treatment. Its tools serve clinicians and drug developers, spanning drug development to clinical decision-making.
Investors · 2
Frequently asked questions
- What does Okomera do?
- Okomera builds a platform combining miniaturized tumor-on-chip technology and AI imaging to analyze patient-derived biopsies and predict personalized drug response for cancer treatment. Its tools serve clinicians and drug developers, spanning drug development to clinical decision-making.
- Who are Okomera's investors?
- Okomera's investors include Polytechnique Ventures, Resonance VC.